1. Centers for Disease Control and Prevention. History of Ebola virus disease (EVD) outbreaks. 2022 [cited 2023 Jul 7]. https://www.cdc.gov/vhf/ebola/history/chronology.html
2. European Medicines Agency. Zabdeno. 2020 Jul [cited 2023 Mar 3]. https://www.ema.europa.eu/en/medicines/human/EPAR/zabdeno
3. European Medicines Agency. Mvabea. 2020 Nov [cited 2023 Mar 3]. https://www.ema.europa.eu/en/medicines/human/EPAR/mvabea
4. World Health Organization. List of prequalified vaccines [cited 2023 May 16]. https://extranet.who.int/pqweb/vaccines/list-prequalified-vaccines
5. Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.;Barry;PLoS Med,2021